The Commission for Protection of Competition instituted ex officio proceedings against company Zdravstvena ustanova Apoteka Janković to investigate a merger implemented before obtaining clearance under the Law on Protection of Competition, which, based on reasonable grounds to believe, is created by the acquisition of control on the part of Zdravstvena ustanova Apoteka Janković over pharmaceutical operations of Zdravstvena ustanova Apoteka Zrenjanin.

In the investigation procedure, the Commission will assess the criteria provided by the Law (Article 19 of the LPC) on the permissibility of mergers, and in particular, the fact that the case concerns a non-notified merger implemented without authorization and noncompliance by said undertakings with their obligations under the national merger control regime.

The Commission will establish all the relevant facts, evidence, and other elements on which to base its decision on potential actions, that is, deconcentration measures.
The Law provides that concentrations of undertakings are permitted, unless they significantly restrict, distort, or prevent competition on the market of the Republic of Serbia or its part, and especially if that restriction, distortion, or prevention is the result of creating or strengthening of a dominant position.

The conclusion instituting proceedings invites all persons in possession of data, documents, or other relevant information that could contribute to the accurate fact-finding in this proceedings to forthwith present said evidence to the Commission for Protection of Competition at 25 Savska St., 4th Floor, Belgrade.